Wedbush Securities’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $170K | Sell |
|
|||||
|
2025
Q2 | $153K | Buy |
|
|||||
|
2025
Q1 | $149K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $245K | Sell |
|
|||||
|
2024
Q2 | $236K | Buy |
|
|||||
|
2024
Q1 | $210K | Sell |
|
|||||
|
2023
Q4 | $271K | Sell |
|
|||||
|
2023
Q3 | $284K | Buy |
|
|||||
|
2023
Q2 | $267K | Buy |
|
|||||
|
2023
Q1 | $251K | Buy |
|
|||||
|
2022
Q4 | $238K | Buy |
|
|||||
|
2022
Q3 | $196K | Buy |
|
|||||
|
2022
Q2 | $199K | Buy |
|
|||||
|
2022
Q1 | $218K | Buy |
|
|||||
|
2021
Q4 | $196K | Buy |
|
|||||
|
2021
Q3 | $210K | Sell |
|
|||||
|
2021
Q2 | $217K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $187K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $239K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $174K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $285K | Buy |
|
|||||
|
2015
Q3 | $235K | Sell |
|
|||||
|
2015
Q2 | $312K | Buy |
|
|||||
|
2015
Q1 | $247K | Buy |
|